Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Acarix AB

Market Cap 296M 30.79M 26.9M 24.88M 23.22M 43.6M 2.91B 43.92M 115M 1.43B 116M 113M 4.97B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 296M 30.79M 26.9M 24.88M 23.22M 43.6M 2.91B 43.92M 115M 1.43B 116M 113M 4.97B EV / Sales 2026 *
15.5x
EV / Sales 2027 * 4.25x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 week-3.80%
Current month-5.59%
1 month-13.64%
3 months-18.28%
6 months-18.72%
Current year-11.63%
1 week 0.02
Extreme 0.0152
0.02
1 month 0.02
Extreme 0.0152
0.02
Current year 0.02
Extreme 0.0152
0.04
1 year 0.02
Extreme 0.0152
0.04
3 years 0.01
Extreme 0.0112
0.05
5 years 0.01
Extreme 0.0112
0.17
10 years 0.01
Extreme 0.0112
2.37
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Operating Officer 62 01/12/2009
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 50 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.80% - - 30.87M
+0.05%-6.94%+2.11%-32.78% 15.63B
-0.25%-5.86%+32.33%+55.38% 1.57B
+1.61%+2.93%-25.72%+26.68% 1.12B
-5.34%-11.46%-53.35%-84.92% 932M
+1.14%+5.49%-13.89%-49.07% 677M
+5.28%+2.41%-36.37%-55.28% 554M
-0.19%+0.48%+33.97%-54.29% 444M
+0.80%-1.10%-54.60%-60.93% 382M
-0.73%-7.49%-26.28%-25.06% 341M
Average +0.16%-1.03%-15.75%-31.14% 2.41B
Weighted average by Cap. +0.22%-6.04%-1.80%-27.46%

Financials

2026 *2027 *
Net sales 19.1M 1.99M 1.74M 1.61M 1.5M 2.82M 188M 2.84M 7.43M 92.4M 7.47M 7.3M 321M 69.5M 7.24M 6.32M 5.85M 5.46M 10.25M 684M 10.32M 27.04M 336M 27.17M 26.58M 1.17B
Net income -28.9M -3.01M -2.63M -2.43M -2.27M -4.26M -284M -4.29M -11.24M -140M -11.3M -11.05M -486M 2.4M 250K 218K 202K 189K 354K 23.61M 356K 934K 11.61M 938K 918K 40.33M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change
22/06/26 0.0152 0.00%
19/06/26 0.0152 0.00%
18/06/26 0.0152 -1.30%
17/06/26 0.0154 -2.53%
16/06/26 0.0158 0.00%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!